Greetings - been away for a day and unable to get back to you baldfatugly (like the moniker!) till now. No, don't have those types of answers yet, and really wasn't shooting for that at first. But will add to our requests for additional info. Just starting on this project of getting stock-related answers from ENCC. I will look for your questions, and questions from others going forward, that will be subsequently submitted.
Please remember, there are securities laws that prohibit Mr. Sharp from providing material information to one group like us exclusively,, versus the general investing public (i.e., no preferential treatment permitted).
Below are slightly edited answers to my questions from Mr. Sharp:
Mr. Sharp intro: "The key thing to remember is we have created something the drug testing industry has never had. It takes time to change the way they engage with customers and get them comfortable with technology in general. That being said, much has changed over the last few years and we are really headed in a great direction...I focus on growing our business and taking this company to the next level. We continue to put all our earnings back into people and technology resources. That is the only way to get where we all want to go. Here are answers to your questions:"
*Are there significant numbers of new accounts/clients, as a result of arrangement with Alere?
"We do continue to add customers as Alere sends them to us. This is still a new initiative with them, they are a huge company and in the middle of being acquired. I anticipate more growth in The Third and Fourth quarter from our relationship with them."
*What does Alere get out of the arrangement?
"It is just a referral arrangement where customers are sent to us to solve their compliance needs. This provides Alere customers an industry solution that Alere doesn’t offer as part of their product set. Alere receives no compensation whatsoever.
*Outside of Alere, what are ENCC's new business development results?
"There are other labs, TPA’s (Third Party Administrators) and large franchise deals we have either closed, are integrating or working through the sales process. I can’t name them, but they are large opportunities that can add thousands or 10’s of thousands of users to us. All of these want direct integration onto their ordering platforms. This takes a long time since we are at the mercy of their development schedules in order to complete the integration."
*Any anticipated positives for results for period ending 6/30/17?
"I can’t say anything other than what has been reported through press releases. Each quarter we hope to steadily grow our revenue. The report will be posted sometime in the next few weeks.
*Will the company's share structure be disclosed with your quarterly results?
"I always add that to the quarterly report and update the OTC site as well, so, yes it will be. We report, authorized, outstanding and the float balances. These come directly from the transfer agent. If people are looking for who owns what position, I am not allowed to disclose those numbers. I have shareholder reports, but they are not for public “consumption.”
*Anything else you would like to have me pass on to our board members?
"I can tell you this and I know there are those that say Bill Judge and I sell our shares, but we have never sold a single share since we have taken control of this entity. We both own more than we started with (restricted stock has been issued to us since we haven’t taken much compensation for a few years) and this is always disclosed on the quarterly report. We spend a lot of time and our own money building this company and changing the marketplace we service."
